Burberry Group PLC (BRBY)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 1,072.00 |
|---|---|
| 52-week range | 953.40 – 1,376.50 |
| Return, 1 month / 3 months | +4.7% / +3.3% |
| Return, 1 year / 3 years | −13.7% / −34.0% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 36.2% |
| Worst drawdown (1 year) | -28.1% |
| Average daily value traded | 2,228.70M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Burberry Group is a British luxury fashion company based in London. It designs and sells clothing, accessories and fragrance under its own brand, including outerwear such as trench coats and its distinctive check pattern applied to scarves, bags and other goods. Its customers are affluent shoppers buying luxury fashion, and it operates through its own stores, concessions and online channels in markets around the world.
Burberry Group PLC trades under the code BRBY on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Burberry Group PLC (BRBY) trades on the London Exchange in UK. It last closed at GBX 1,072.00 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,994 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.7% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -21.2% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 3.3% | ||
| 6-month return | -6.8% | ||
| 12-month return, skipping the last month | -17.6% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.1% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 2,228.70M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +4.7% |
| 3 months | +3.3% |
| 6 months | −6.8% |
| 1 year | −13.7% |
| 3 years | −34.0% |
| 5 years | −36.6% |
Signals
| 50-day / 200-day average | 1,051.46 / 1,116.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 30.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jun 2024 | GBP 0.4270 |
| 14 Dec 2023 | GBP 0.1830 |
| 29 Jun 2023 | GBP 0.4450 |
| 15 Dec 2022 | GBP 0.1650 |
| 30 Jun 2022 | GBP 0.3540 |
| 16 Dec 2021 | GBP 0.1160 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.